As AI tools like ChatGPT spread across campuses, colleges are rethinking exams with oral tests, handwritten work, and ...

International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors ...

Title: Results from the randomized Phase 2 study (1801 Part 3B) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) versus GnP in previously untreated metastatic pancreatic ductal adenocarcinoma ...

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on ...

Abstracts for oral presentations should be submitted by March 9, 2026. AATCC reserves the right to accept, place on a waiting ...

Zumba reports that becoming a group fitness instructor allows you to pursue fitness passions while helping others, with ...

If he likes you, he will make time to see you. Not only that, but he will make specific plans to do so. It doesn’t have to be ...

– NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE(-) level) by independent review committee – – In four out of five pending patients, MRD negativity in bone marrow ...

From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA.

Red Light Busking presents Kanda Vol.1 – Bedroom Shut, Music Up tells the story of two brothers of Caribbean descent who are ...

The MarketWatch News Department was not involved in the creation of this content. -- Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled ...

Detailed price information for Ernexa Therapeutics Inc (ERNA-Q) from The Globe and Mail including charting and trades.